ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,757Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 2116

$1.26M Total Retail Price of All Prescriptions

Rank: 62 out of 2116

659 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Jersey
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 659 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 700 680 138 1 1
SIMVASTATIN 646 598 136 2 2
LEVOTHYROXINE SODIUM 466 417 89 3 4
OMEPRAZOLE 451 398 82 4 5
ATORVASTATIN CALCIUM 451 415 95 4 3
FUROSEMIDE 377 328 80 6 6
METFORMIN HCL 351 294 73 7 8
METOPROLOL SUCCINATE 286 281* 58 8 9
VALSARTAN-HYDROCHLOROTHIAZIDE 282 253 62 9 37
NEXIUM 281 276* 59 10 20
DONEPEZIL HCL 280 275* 46 11 22
MELOXICAM 272 259 74 12 50
ALENDRONATE SODIUM 264 233 57 13 39
AZITHROMYCIN 255 227 184 14 35
CARVEDILOL 253 248* 46 15 21
ALPRAZOLAM 252 231 72 B 16 14
CLOPIDOGREL 242 237* 40 17 12
SERTRALINE HCL 227 222* 50 18 28
ZOLPIDEM TARTRATE 216 193 49 19 17
CRESTOR 198 172 42 20 18
GLIMEPIRIDE 196 191* 40 21 34
DIOVAN 171 166* 34 22 16
JANUVIA 165 165 24 23 31
NAMENDA 154 149* 21 24 24
POTASSIUM CHLORIDE 150 150 29 25 25
LOSARTAN POTASSIUM 146 135 32 26 15
METOPROLOL TARTRATE 134 115 34 27 10
ALLOPURINOL 130 125* 25 28 48
MECLIZINE HCL 127 115 36 29 100
LOSARTAN-HYDROCHLOROTHIAZIDE 126 121* 29 30 46
LOVAZA 122 102 29 31 52
LEVOCETIRIZINE DIHYDROCHLORIDE 116 102 30 32 98
HYDROCHLOROTHIAZIDE 116 102 23 32 13
ADVAIR DISKUS 114 109* 33 34 41
BENICAR HCT 109 98 17 35 128
PROAIR HFA 108 93 32 36 44
METFORMIN HCL ER 106 101* 24 37 64
LISINOPRIL 104 104 20 38 7
LEVOFLOXACIN 103 98* 69 39 59
PRAVASTATIN SODIUM 102 80 21 40 19
CELEBREX 95 90* 21 41 62
SYNTHROID 94 89* 21 42 42
DIOVAN HCT 92 77 24 43 170
BENICAR 92 87* 15 43 97
LANTUS SOLOSTAR 89 75 18 45 70
TAMSULOSIN HCL 85 80* 12 46 27
TORSEMIDE 84 79* 14 47 119
MONTELUKAST SODIUM 82 69 17 48 40
GABAPENTIN 80 75* 25 49 23
FLUTICASONE PROPIONATE 79 59 16 50 43
WARFARIN SODIUM 79 79 15 50 11
CLONAZEPAM 78 48 11 B 52 57
LORAZEPAM 77 77 13 B 53 38
IBANDRONATE SODIUM 77 72* 21 53 110
ATENOLOL 76 64 18 55 26
ESCITALOPRAM OXALATE 75 75 15 56 33
SYMBICORT 74 60 24 57 132
FENOFIBRATE* 74 47 12 57 85
AMLODIPINE BESYLATE-BENAZEPRIL 73 73 12 59 66
FENOFIBRATE* 69 <11 <11 60 85
ENALAPRIL MALEATE 66 66 17 61 32
VOLTAREN 66 61* 26 61 73
CLOTRIMAZOLE-BETAMETHASONE 66 61* 34 61 95
EXELON 65 <11 <11 64 111
LYRICA 65 60* 20 64 75
CYMBALTA 64 47 13 66 49
CLONIDINE HCL 63 63 11 67 69
NAPROXEN 60 42 22 68 91
BYSTOLIC 60 55* 12 68 86
SPIRIVA 59 59 15 70 65
KLOR-CON M20 58 34 11 71 116
HYDROCODONE-ACETAMINOPHEN 57 23 13 S3 72 51
PAROXETINE HCL 56 42 12 73 78
UNIFINE PENTIPS 55 <11 <11 74 246
PANTOPRAZOLE SODIUM 54 42 11 75 29
CIPROFLOXACIN HCL 53 48* 39 76 83
LIDODERM 53 53 11 76 67
MEGESTROL ACETATE 53 48* 16 R 76 203
WELCHOL 51 <11 <11 79 148
RAMIPRIL 51 51 11 79 53
LANTUS 51 <11 <11 79 79
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.